CELLDEX THERAPEUTICS INC NEW's ticker is CLDXXXXX and the CUSIP is 15117B103. A total of 141 filers reported holding CELLDEX THERAPEUTICS INC NEW in Q3 2016. The put-call ratio across all filers is 1.05 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2018 | $130,000 | -9.7% | 55,993 | +10.5% | 0.00% | – |
Q4 2017 | $144,000 | +82.3% | 50,684 | +83.9% | 0.00% | – |
Q3 2017 | $79,000 | +203.8% | 27,562 | +157.5% | 0.00% | – |
Q2 2017 | $26,000 | -89.1% | 10,704 | -83.8% | 0.00% | – |
Q1 2017 | $238,000 | +4.4% | 65,884 | +2.2% | 0.00% | – |
Q4 2016 | $228,000 | +230.4% | 64,475 | +278.3% | 0.00% | – |
Q3 2016 | $69,000 | -79.2% | 17,042 | -77.4% | 0.00% | -100.0% |
Q2 2016 | $331,000 | +353.4% | 75,450 | +288.4% | 0.00% | – |
Q1 2016 | $73,000 | -81.9% | 19,425 | -24.7% | 0.00% | -100.0% |
Q4 2015 | $404,000 | +39.3% | 25,796 | -6.1% | 0.00% | 0.0% |
Q3 2015 | $290,000 | -77.4% | 27,479 | -45.9% | 0.00% | -66.7% |
Q2 2015 | $1,282,000 | -13.4% | 50,817 | -4.3% | 0.00% | 0.0% |
Q1 2015 | $1,480,000 | +59.8% | 53,086 | +4.6% | 0.00% | +50.0% |
Q4 2014 | $926,000 | +84.1% | 50,733 | +30.6% | 0.00% | +100.0% |
Q3 2014 | $503,000 | +50.1% | 38,849 | +89.1% | 0.00% | 0.0% |
Q2 2014 | $335,000 | -0.3% | 20,543 | +8.1% | 0.00% | 0.0% |
Q1 2014 | $336,000 | -37.9% | 18,996 | -14.9% | 0.00% | 0.0% |
Q4 2013 | $541,000 | +13.7% | 22,328 | +66.1% | 0.00% | 0.0% |
Q3 2013 | $476,000 | +121.4% | 13,444 | -2.2% | 0.00% | 0.0% |
Q2 2013 | $215,000 | – | 13,742 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Byrne Asset Management LLC | 86 | $2,000 | 0.00% |